NewAmsterdam Pharma Co N.V. 8-K

What Happened

• NewAmsterdam Pharma Company N.V. filed an 8-K (dated June 3, 2026) reporting the results of its annual general meeting held June 2, 2026 in Amsterdam. Shareholders approved the NewAmsterdam Pharma 2026 Employee Stock Purchase Plan (ESPP), which became effective upon shareholder approval.
• The ESPP allows eligible employees to buy Ordinary Shares via payroll deductions over generally six-month Purchase Periods, with purchases made at a 15% discount to the lower of the market price at the start or end of each Purchase Period. Up to 1,150,000 Ordinary Shares may be issued under the plan. The ESPP will automatically terminate on June 2, 2036 unless earlier terminated by the Board or Compensation Committee.
• The filing also reports full voting results for nine AGM proposals, including approval of annual accounts, auditor ratification (Deloitte Accountants B.V.), re-appointment of two non-executive directors, shareholder authorization to issue shares and to limit pre-emption rights, and a non-binding advisory say-on-pay vote for 2025 compensation.

Key Details

• Record date and quorum: 116,903,979 ordinary shares eligible to vote (record date May 7, 2025); 91,538,612 shares (≈78.3%) voted in person or by proxy.
• ESPP vote: 86,221,442 For, 139,927 Against, 25,633 Abstain; up to 1,150,000 Ordinary Shares reserved under the plan; purchases at a 15% discount; typical Purchase Period ≈6 months; plan expires June 2, 2036.
• Notable AGM votes: authorization to issue shares (Proposal 6) passed with 59,539,558 For vs 26,801,646 Against; authorization to limit/exclude pre-emption rights (Proposal 7) passed 57,890,766 For vs 28,450,917 Against. Re-appointment votes: John W. Smither (85,375,639 For) and Janneke van der Kamp (75,256,863 For, 9,899,189 Against). Say-on-pay (Proposal 9) passed 81,100,259 For vs 4,946,963 Against.
• The full ESPP text is filed as Exhibit 10.1 to the 8-K; a detailed description was included in the Company’s definitive proxy statement filed May 6, 2026.

Why It Matters

• The ESPP encourages employee ownership and alignment with shareholders by letting employees buy shares at a discount, which can help retention and motivation. It also creates potential dilution — up to 1,150,000 new shares — which investors should monitor when assessing share count and dilution trends.
• The AGM results show shareholder support for governance items (auditor ratification, say-on-pay) but also sizable opposition on share-issuance and pre-emption authorizations and one director reappointment, which could reflect investor concerns about dilution or governance that investors may want to track.